A Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Single and Multiple Doses of GSK1292263, a Novel GPR119 Agonist
Nunez JD, Lewis EW, Swan SK, Bush MA, Cannon C, McMullen SL, Collins DA, Feldman PL. A Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Single and Multiple Doses of GSK1292263, a Novel GPR119 Agonist. American Diabetes Association; June 26 2010.